Head-to-head · Cost-Efficiency Index
Blue Haven RX vs HealthSource
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Blue Haven RX
Shoppers who read the FAQ carefully before trusting the homepage price.
Visit Blue Haven RXHealthSource
Cost-first shoppers who want nothing distinguishing was found — the least-disclosed of the sites researched here.
Visit HealthSourceThe verdict
Blue Haven RX and HealthSource tie on the Cost-Efficiency Index at 61/100, so neither wins outright on the numbers. For most shoppers we'd start with Blue Haven RX (ranked #225, a hair above #229) — Shoppers who read the FAQ carefully before trusting the homepage price. But HealthSource is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Blue Haven RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Blue Haven RX | HealthSource |
|---|---|---|
| Cost-Efficiency Index | 61/100 | 61/100 |
| Semaglutide / mo | $149/mo (all doses, compounded) | Not disclosed |
| Tirzepatide / mo | $179/mo (all doses, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,788 | — |
| Tirzepatide / yr (modeled) | $2,148 | — |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #225 | #229 |
Blue Haven RX
61/100Where the value is
- Claims flat, dose-independent pricing ('no price increases' regardless of dose)
- Routes to established physician networks (Wasef Health, Beluga Health) rather than an unknown in-house provider
- Payments held until doctor approval, per site copy, reducing risk of paying for a declined prescription
The tradeoffs
- Internal pricing contradiction: homepage says tirzepatide is $179/month, FAQ says $259/month
- No named medical director
HealthSource
61/100Where the value is
- Offers an oral tirzepatide option in addition to injectable, which not every site in this set does
- States medication ships from an 'FDA 503A licensed partner pharmacy'
- 3-5 business day shipping stated
The tradeoffs
- Billed every 4 weeks rather than by calendar month, which adds roughly one extra charge per year versus a true monthly rate — an 8%+ real-cost increase the headline price doesn't convey
- The compounding pharmacy is never named, only described generically as 'FDA 503A licensed partner pharmacy'
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.